esmolol has been researched along with flestolol in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gorczynski, RJ; Hwang, TF; Murthy, VS; Rosen, LB | 1 |
| Burge, J; Katz, RJ; Keefe, D; Laddu, AR; Somberg, JC; Steinberg, JS | 1 |
| Frishman, WH; Murthy, S; Strom, JA | 1 |
| Frishman, WH; Murthy, VS | 1 |
2 review(s) available for esmolol and flestolol
| Article | Year |
|---|---|
Ultra-short-acting beta-adrenergic blockers.
Topics: Adrenergic beta-Antagonists; Cardiovascular Diseases; Fluorobenzenes; Humans; Hypotension; Propanolamines | 1988 |
Controlled beta-receptor blockade with esmolol and flestolol.
Topics: Adrenergic beta-Antagonists; Animals; Drug Interactions; Fluorobenzenes; Hemodynamics; Humans; Propanolamines | 1988 |
1 trial(s) available for esmolol and flestolol
| Article | Year |
|---|---|
Safety and efficacy of flestolol, a new ultrashort-acting beta-adrenergic blocking agent, for supraventricular tachyarrhythmias.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atrial Fibrillation; Atrial Flutter; Blood Pressure; Clinical Trials as Topic; Female; Fluorobenzenes; Half-Life; Humans; Hypotension; Male; Middle Aged; Myocardial Contraction; Propanolamines; Time Factors | 1986 |
1 other study(ies) available for esmolol and flestolol
| Article | Year |
|---|---|
Controlled beta-receptor blockade with flestolol: a novel ultrashort-acting beta-blocker.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Drug Interactions; Female; Fluorobenzenes; Heart Rate; Isoproterenol; Kinetics; Liver; Male; Propanolamines; Rabbits; Reserpine | 1987 |